1 Bien CG, Vincent A, Barnett MH, Becker AJ, Blumcke I, Graus F, Jellinger KA, Reuss DE, Ribalta T, Schlegel Jet al (2012) Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 135: 1622-1638 Doi 10.1093/brain/aws082
2 Camdessanché JP, Streichenberger N, Cavillon G, Rogemond V, Jousserand G, Honnorat J, Convers P, Antoine JC (2011) Brain immunohistopathological study in a patient with anti-NMDAR encephalitis. Eur J Neurol 18: 929-931 Doi 10.1111/j.1468-1331.2010.03180.x
3 Castillo-Gomez E, Oliveira B, Tapken D, Bertrand S, Klein-Schmidt C, Pan H, Zafeiriou P, Steiner J, Jurek B, Trippe Ret al (2017) All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class. Mol Psychiatry 22: 1776-1784 Doi 10.1038/mp.2016.125
4 Citri A, Malenka RC (2008) Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology 33: 18-41 Doi 10.1038/sj.npp.1301559
5 Dabner M, McCluggage WG, Bundell C, Carr A, Leung Y, Sharma R, Stewart CJ (2012) Ovarian teratoma associated with anti-N-methyl D-aspartate receptor encephalitis: a report of 5 cases documenting prominent intratumoral lymphoid infiltrates. Int J Gynecol Pathol 31: 429-437 Doi 10.1097/PGP.0b013e31824a1de2
6 Dalmau J (2016) NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: The 2016 Cotzias Lecture. Neurology 87: 2471-2482 Doi 10.1212/wnl.0000000000003414
7 Dalmau J, Geis C, Graus F (2017) Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. Physiol Rev 97: 839-887 Doi 10.1152/physrev.00010.2016
8 Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. The Lancet Neurology 7: 1091-1098 Doi 10.1016/s1474-4422(08)70224-2
9 Ganor Y, Goldberg-Stern H, Cohen R, Teichberg V, Levite M (2014) Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) can be produced in DBA/2J mice, lower seizure threshold and induce abnormal behavior. Psychoneuroendocrinology 42: 106-117 Doi 10.1016/j.psyneuen.2014.01.005
10 Ganor Y, Gottlieb M, Eilam R, Otmy H, Teichberg VI, Levite M (2005) Immunization with the glutamate receptor-derived peptide GluR3B induces neuronal death and reactive gliosis, but confers partial protection from pentylenetetrazole-induced seizures. Exp Neurol 195: 92-102 Doi 10.1016/j.expneurol.2005.04.002
11 Gleichman AJ, Spruce LA, Dalmau J, Seeholzer SH, Lynch DR (2012) Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci 32: 11082-11094 Doi 10.1523/JNEUROSCI.0064-12.2012
12 Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind Met al (2016) A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology 15: 391-404 Doi 10.1016/s1474-4422(15)00401-9
13 Greene M, Lancaster E (2015) Assessing the incidence of anti-NMDAR encephalitis. Arch Dis Child 100: 512-513 Doi 10.1136/archdischild-2014-307978
14 Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, Gleichman AJ, Balice-Gordon R, Rosenfeld MR, Lynch Det al (2014) Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. The Lancet Neurology 13: 167-177 Doi 10.1016/s1474-4422(13)70282-5
15 Hansen KB, Yi F, Perszyk RE, Furukawa H, Wollmuth LP, Gibb AJ, Traynelis SF (2018) Structure, function, and allosteric modulation of NMDA receptors. J Gen Physiol 150: 1081-1105 Doi 10.1085/jgp.201812032
16 Hemmer B, Kerschensteiner M, Korn T (2015) Role of the innate and adaptive immune responses in the course of multiple sclerosis. The Lancet Neurology 14: 406-419 Doi 10.1016/s1474-4422(14)70305-9
17 Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, Parsons TD, Lynch DR, Dalmau J, Balice-Gordon RJ (2010) Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30: 5866-5875 Doi 10.1523/JNEUROSCI.0167-10.2010
18 Jones BE, Tovar KR, Goehring A, Jalali-Yazdi F, Okada NJ, Gouaux E, Westbrook GL (2019) Autoimmune receptor encephalitis in mice induced by active immunization with conformationally stabilized holoreceptors. Sci Transl Med 11: Doi 10.1126/scitranslmed.aaw0044
19 Jurek B, Chayka M, Kreye J, Lang K, Kraus L, Fidzinski P, Kornau HC, Dao LM, Wenke NK, Long Met al (2019) Human gestational N-methyl-d-aspartate receptor autoantibodies impair neonatal murine brain function. Ann Neurol 86: 656-670 Doi 10.1002/ana.25552
20 Manto M, Dalmau J, Didelot A, Rogemond V, Honnorat J (2010) In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction. Orphanet J Rare Dis 5: 31 Doi 10.1186/1750-1172-5-31
21 Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, Sangha N, Martinez-Lage M, Dalmau J (2011) Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology 77: 589-593 Doi 10.1212/WNL.0b013e318228c136
22 Moscato EH, Peng X, Jain A, Parsons TD, Dalmau J, Balice-Gordon RJ (2014) Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 76: 108-119 Doi 10.1002/ana.24195
23 Potier M, Georges F, Brayda-Bruno L, Ladepeche L, Lamothe V, Al Abed AS, Groc L, Marighetto A (2016) Temporal Memory and Its Enhancement by Estradiol Requires Surface Dynamics of Hippocampal CA1 N-Methyl-D-Aspartate Receptors. Biol Psychiatry 79: 735-745 Doi 10.1016/j.biopsych.2015.07.017
24 Tachibana N, Shirakawa T, Ishii K, Takahashi Y, Tanaka K, Arima K, Yoshida T, Ikeda S-I (2010) Expression of various glutamate receptors including N-methyl-D-aspartate receptor (NMDAR) in an ovarian teratoma removed from a young woman with anti-NMDAR encephalitis. Intern Med 49: 2167-2173 Doi 10.2169/internalmedicine.49.4069
25 Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez Eet al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. The Lancet Neurology 12: 157-165 Doi 10.1016/s1474-4422(12)70310-1
26 Tsien JZ, Huerta PT, Tonegawa S (1996) The Essential Role of Hippocampal CA1 NMDA Receptor–Dependent Synaptic Plasticity in Spatial Memory. Cell 87: 1327-1338 Doi 10.1016/s0092-8674(00)81827-9
27 Tuzun E, Zhou L, Baehring JM, Bannykh S, Rosenfeld MR, Dalmau J (2009) Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol 118: 737-743 Doi 10.1007/s00401-009-0582-4
28 Venkatesan A, Adatia K (2017) Anti-NMDA-Receptor Encephalitis: From Bench to Clinic. ACS Chem Neurosci 8: 2586-2595 Doi 10.1021/acschemneuro.7b00319
29 Vincent A, Bien CG (2008) Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults. The Lancet Neurology 7: 1074-1075 Doi 10.1016/s1474-4422(08)70225-4
30 Warren N, Siskind D, O'Gorman C (2018) Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis. Acta Psychiatr Scand 138: 401-408 Doi 10.1111/acps.12941
31 Wenke NK, Kreye J, Andrzejak E, van Casteren A, Leubner J, Murgueitio MS, Reincke SM, Secker C, Schmidl L, Geis Cet al (2019) N-methyl-D-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit. Ann Neurol 85: 771-776 Doi 10.1002/ana.25460
32 Zhang Q, Tanaka K, Sun P, Nakata M, Yamamoto R, Sakimura K, Matsui M, Kato N (2012) Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients. Neurobiol Dis 45: 610-615 Doi 10.1016/j.nbd.2011.09.019